Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00057070 · ClinicalTrials.gov registry record · NA
Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET
A NA study of Smoking Cessation and Randomized Controlled Trial, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- NA
- Development phase
- 1,900
- Enrollment target
- 2
- Study locations
NCT00057070: Completed NA study of Smoking Cessation and Randomized Controlled Trial, sponsored by US Department of Veterans Affairs.
NCT00057070 is a NA study of Smoking Cessation and Randomized Controlled Trial that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 1,900 participants, above the 465-participant average among 188 other Smoking Cessation trials with a reported enrollment target (309% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00057070, a NA study of Smoking Cessation and Randomized Controlled Trial, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,900 participants
- Enrollment target
- 2
- Study locations
Study Summary
The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation Clinical Practice Guideline provides specific recommendations for treating tobacco dependence. Despite their strong evidence base, however, these recommendations have not been fully integrated into clinical practice within the VHA. Recent data suggest that logistical difficulties associated with identifying and linking smokers with appropriate treatments may explain why the PHS Smoking Cessation Guideline has not been more broadly implemented.
Conditions Studied
Interventions
- PROCEDURE Smoking cessation information, collection, and dissemination
Study Locations (2)
Minnesota
- Minneapolis VA Health Care System, Minneapolis, MN - Minneapolis
Washington
- VA Puget Sound Health Care System Seattle Division, Seattle, WA - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,900 participants |
| Start Date | 2001-10 |
| Est. Completion | 2003-09 |
| Phase | NA |
What the finished NCT00057070 record still lists
NCT00057070 is an interventional study that assigns participants to a tested intervention. Its 1,900 participants enrollment target places it among the larger protocols in the corpus, above the 465-participant average among 188 other Smoking Cessation trials with a reported enrollment target (309% higher).
The record links to 2 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 1 intervention - of which Smoking cessation information, collection, and dissemination is the first listed.
NCT00057070 reports a single indexed study location in Minnesota, Washington.
Frequently Asked Questions
What is clinical trial NCT00057070 about?
NCT00057070 is a clinical study titled "Facilitating Implementation of the PHS Smoking Cessation Guidelines - RESET". The adverse impact of tobacco use on disease prevalence and health care costs is well documented. Hence, finding effective ways to reduce tobacco dependence is an essential component of improving the outcomes, quality and efficiency of VHA care. The U.S. Public Health Service (PHS) Smoking Cessation...
What is the current status of trial NCT00057070?
This trial is currently completed. It is a NA study. The enrollment target is 1,900 participants. The study started on 2001-10. Estimated completion is 2003-09.
What conditions does trial NCT00057070 study?
This clinical trial studies the following conditions: Smoking Cessation, Randomized Controlled Trial.
What interventions are being tested in trial NCT00057070?
The interventions under investigation include: Smoking cessation information, collection, and dissemination (PROCEDURE).
Who is sponsoring clinical trial NCT00057070?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00057070 being conducted?
This trial has 2 study locations across Minnesota, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00057070's enrollment target sits among peer trials
1,900 10th of 188 higher than 179 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03729180 · 1,900 participants · NA
The ImPreSS Trial: Pharmacogenomic Decision Making at Time of Surgery
- NCT05712200 · 1,900 participants · Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- NCT06929806 · 1,900 participants · Phase 3
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
- NCT07228234 · 1,900 participants · NA
Evaluating Mammography Communication Approaches
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia